Back to search

University of Ioannina

Η συμβολή του SPECT και MRI στη διάγνωση του κακοήθους γλοιώματος και ακτινονέκρωσης

Abstract

dc:description

Morphologic characterization of brain tumors by magnetic resonance imaging (MRI) and computed tomography (CT) is well established. However, functional metabolic imaging by single-photon emission computed tomography (SPECT) and positron emission tomography (PET) are also increasingly important imaging tools for noninvasive assessment of brain tumors. In this study we evaluated brain SPECT with technetium-99m Tetrofosmin (99mTc-TF) in the differentiation of tumor recurrence from radiation necrosis and in the noninvasive assessment of gliomas aggressiveness. Radiation necrosis vs tumor recurrence The primary therapeutic management of gliomas consists of surgery, followed by a combination of adjuvant external-beam radiotherapy and chemotherapy. Complications may, however, occur; an increasing number of patients present on follow-up with symptoms and signs that may be due to recurrence or regrowth of residual tumor, or result from postirradiation injury and necrosis. Morphologic characterization by MRI and CT usually faces inherent limitations in discriminating between viable tumor tissue and radionecrosis. Functional metabolic imaging by PET and SPECT provides a complemecomplementary approach to this critical issue, although PET is often cost-prohibitive and not widely available. Brain SPECT has been suggested as a useful modality for the assessment of radiation-induced changes of the central nervous system. Various radiotracers have been evaluated; yet, little has been reported to date on the potential of 99mTc-TF for brain tumor 92 imaging and its capability to discriminate between radiation injury and viable tumor. This pilot study aimed to evaluate the accuracy of 99mTc-TF brain SPECT in differentiating radiation injury from tumor recurrence. Glioma assessment The prognosis of cancer depends on the biological behaviour of the tumor, which is determined by various cellular characteristics, such as proliferation, resistance to chemotherapeutic drugs, and capacity to create metastasis. Despite the use of various kinds of prognostic indicators, it is still very difficult to predict the biological behavior of all cancers. The proliferation potential of gliomas of the central nervous system (CNS) is important for the patient management and has significant prognostic implications; therefore, identification of biological markers for the assessment of the proliferative activity in these tumors is essential. Various methods have been proposed towards this scope, such as the bromodeoxyuridine (BUdR) labelling index, flow cytometry, as well as various immunohistological markers including MIB-1 antibody staining to the Ki-67 antigen, staining to the proliferating cell nuclear antigen (PCNA), argyrophilic staining to nucleolar organizing regions (AgNOR), DNA polymerase-α, p105, and DNA topoisomerase II-a. The MIB-1 antibody reacts to the Ki-67 nuclear antigen in formalin-fixed tissue.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Alexiou, Georgios
  • Αλεξίου, Γεώργιος

Subjects

dc:subject × 13

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/17716

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Alexiou, Georgios; Αλεξίου, Γεώργιος. Η συμβολή του SPECT και MRI στη διάγνωση του κακοήθους γλοιώματος και ακτινονέκρωσης. University of Ioannina, 2008. http://hdl.handle.net/10442/hedi/17716